drugset / Trial / NCT00206375
Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism
Phase 4
Terminated
16 enrolled
Baylor College of Medicine
Eli Lilly and Company · collabTAP Pharmaceutical Products Inc. · collab
RandomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to see if giving growth hormone and Lupron along with thyroid hormone will improve final height in patients with long term hypothyroidism. Lupron is a medicine which is used to delay puberty and to prevent early closure of growing bones which might increase growth potential. Growth hormone is used to restore growth rate. This study will include children with "short term" and "long term" hypothyroidism.
Timeline
- Start
- 2003-05
- Primary completion
- 2011-09
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Leuprolide | Other / unclassified | — | — |
| Subject | Somatropin | Protein / enzyme biologic | — | — |
| Background | Levothyroxine | Other / unclassified | — | — |